AbbVie Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
AbbVie Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue61.1656.3354.3258.0556.2045.8033.2732.75
Cost of Revenue17.3416.6916.7317.4117.4515.397.447.72
Gross Profit43.8239.6537.5940.6438.7530.4225.8325.04
Operating Expenses
Research & Development9.018.137.046.518.057.766.7910.75
Selling, General & Administrative13.8413.1912.9015.2612.3511.306.947.40
Operating Expenses22.6021.3119.9321.8320.8319.0612.8418.65
Operating Income21.2118.3317.6618.8117.9211.3612.986.38
Other Income/Expense
Interest Income0.000.650.540.190.040.170.000.20
Interest Expense-2.63-2.81-2.222.232.42-2.450.001.35
Other Income/Expense0.700.270.19-3.29-2.555.613.01-0.04
Income
Income Before Tax6.603.726.2513.4812.993.408.435.20
Income Tax Expense2.36-0.571.381.631.44-1.220.54-0.49
Net Income4.234.284.8611.8411.544.627.885.69
Net Income - Continuous Operations0.004.284.8711.8511.550.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA29.4226.7226.3624.1723.9312.3212.278.31
EBIT21.2118.3317.6615.7115.415.8510.216.55
Depreciation & Amortization8.208.398.708.478.520.670.460.00
Earnings Per Share
Basic EPS2.002.003.007.007.003.005.004.00
Diluted EPS2.002.003.007.006.003.005.004.00
Basic Shares Outstanding1.771.771.771.771.771.671.481.54
Diluted Shares Outstanding1.771.771.771.781.781.671.481.55